1-6 of 6
Qin Wen
Close
Sort by
Journal Articles

Evaluating Effectiveness and Safety of Flumatinib for Chronic Phase Chronic Myeloid Leukemia in (CML-CP) without Optimal Response (Warning, Failure) to Imatinib or/and Dasatinib

Li Weiming, Yanli Zhang, Zhiwei Wu, Qin Wen, Qing Leng, Shuting Wu, Xiaodong Wang, Shiming Chen, Guolin Yuan, Sixuan Qian, Suning Chen, Daozi Jiang, Lianjun Diao, Zhenfang Xi, Hui Wu, Hui Sun, Lijie Yang, Hongjuan Wang, Xuefang Zhang, Yanli Xu, Xielan Zhao, Na Xu, Li Meng, Zunmin Zhu, Youfang Zhao, Meifang Su, Zhuangzhi Yang, Chuancai Liu, Danlei Han, Yu Hu
Journal: Blood
Blood (2023) 142 (Supplement 1): 3171.
https://doi.org/10.1182/blood-2023-179142
Published: 2023
Journal Articles

First-in-Class JAK/Rock Inhibitor Rovadicitinib in Myeloproliferative Neoplasms: A Single Arm, Multicenter, Open-Label, Phase I/Ib Study

Zefeng Xu, Ling Pan, Zhenya Hong, Qingsong Yin, Xuelan Zuo, Qin Wen, Fan Yu, Chunkang Chang, Wei Ling, Dong Wang, Dawei Ding, Zhijian Xiao
Journal: Blood
Blood (2023) 142 (Supplement 1): 1829.
https://doi.org/10.1182/blood-2023-178956
Published: 2023
Journal Articles

Flumatinib Versus Nilotinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Suning Chen, Yanli Zhang, Na Xu, Hui Sun, Li Weiming, Yunfan Yang, Zunmin Zhu, Minghui Duan, Sixuan Qian, Yu Zhu, Jianmin Luo, Xiaodong Wang, Wei Yang, Weiying Gu, Fei Li, Bingcheng Liu, Yunxiao Xu, Zhenfang Liu, Chunling Wang, Yirong Jiang, Li Meng, Qin Wen, Yanli Xu, Xingli Zou, Wei Wang, Yan Xue, Hao Xu, Kehong Bi, Fuling Zhou, Liangming Ma, Rong Fu, Guifang Ouyang, Kaiyang Ding, Depei Wu
Journal: Blood
Blood (2023) 142 (Supplement 1): 1797.
https://doi.org/10.1182/blood-2023-179073
Published: 2023
Journal Articles

Amplifying Sting Activation By Bio-Inspired Nanomedicine for Targeted Acute Myeloid Leukemia Chemo- and Immunotherapy

Xiaoqi Wang, Ruihao Huang, Wei Wu, Jingkang Xiong, Qin Wen, Yunjing Zeng, Ting Chen, Jiali Li, Cheng Zhang, Jiang F. Zhong, Shijie Yang, Xi Zhang
Journal: Blood
Blood (2022) 140 (Supplement 1): 7804–7805.
https://doi.org/10.1182/blood-2022-169445
Published: 2022
Journal Articles

Off-the-Shelf CD33 CAR-NK Cell Therapy for Relapse/Refractory AML: First-in-Human, Phase I Trial

Ruihao Huang, Qin Wen, Xiaoqi Wang, Hongju Yan, Yingying Ma, Wang Mai-Hong, Xiao Han, Li Gao, Lei Gao, Cheng Zhang, Xi Zhang
Journal: Blood
Blood (2022) 140 (Supplement 1): 7450–7451.
https://doi.org/10.1182/blood-2022-170712
Published: 2022
Journal Articles

Tandem Autologous Hematopoietic Stem Cell Transplantation Treatment for Adult T-Cell Lymphoblastic Lymphoma: A Multiple Center Prospective Study in Southwestern China

Yao Liu, Jun Rao, Jiali Li, Qin Wen, Shifeng Lou, Yi Su, MD, Tonghua Yang, Sanbin Wang, Gao Lei, Cheng Zhang, MD PhD, Kong Peiyan, Li Gao, Wang Mai-Hong, Lidan Zhu, Xixi Xiang, Sha Zhou, Xiangui Peng, Jiangfan Zhong, Defu Zeng, MD, Xi Zhang
Journal: Blood
Blood (2018) 132 (Supplement 1): 5747.
https://doi.org/10.1182/blood-2018-99-115705
Published: 2018